A proprietary version of resveratrol tested in a small, short-term study significantly reduced blood sugar in diabetic patients as compared with a placebo group.

The results from the 28-day trial intended to evaluate the safety and efficacy of the drug were announced by Sirtris Pharmaceuticals Inc.